Adlai Nortye Stock (NASDAQ: ANL) stock price, news, charts, stock research, profile.
You can purchase shares of Adlai Nortye (NASDAQ:ANL) through any online brokerage.
Other companies in Adlai Nortye’s space includes: Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), Inozyme Pharma (NASDAQ:INZY), Citius Oncology (NASDAQ:CTOR) and Inovio Pharmaceuticals (NASDAQ:INO).
Adlai Nortye has a consensus price target of $9.00.
The stock price for Adlai Nortye (NASDAQ: ANL) is $1.88 last updated January 14, 2025 at 8:40 AM EST.
There are no upcoming dividends for Adlai Nortye.
Adlai Nortye’s FY earnings are confirmed for Friday, February 28, 2025.
There is no upcoming split for Adlai Nortye.
Adlai Nortye is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.